Your browser doesn't support javascript.
loading
Patterns of lymph node involvement for oral cavity squamous cell carcinoma.
Ludwig, Roman; Werlen, Sandrine; Barbatei, Dorothea; Widmer, Lars; Pouymayou, Bertrand; Balermpas, Panagiotis; Elicin, Olgun; Dettmer, Matthias; Zrounba, Philippe; Giger, Roland; Grégoire, Vincent; Schubert, Adrian; Unkelbach, Jan.
Afiliação
  • Ludwig R; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, Zurich 8091, Switzerland. Electronic address: roman.ludwig@usz.ch.
  • Werlen S; Department of ENT, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland; Head and Neck Anticancer Center, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland.
  • Barbatei D; Department of Radiation Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France.
  • Widmer L; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, Zurich 8091, Switzerland.
  • Pouymayou B; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, Zurich 8091, Switzerland.
  • Balermpas P; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, Zurich 8091, Switzerland.
  • Elicin O; Department of Radiation Oncology, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland.
  • Dettmer M; Institute of Pathology, Klinikum Stuttgart, Stuttgart, Germany; Institute of Tissue Medicine and Pathology, Bern University Hospital, University of Bern, Murtenstrasse 31, Bern 3008, Switzerland.
  • Zrounba P; Department of Head and Neck Surgery, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France.
  • Giger R; Department of ENT, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland; Head and Neck Anticancer Center, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland.
  • Grégoire V; Department of Radiation Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France.
  • Schubert A; Department of ENT, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland; Head and Neck Anticancer Center, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland; Department of ENT, Head and Neck
  • Unkelbach J; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, Zurich 8091, Switzerland.
Radiother Oncol ; 200: 110474, 2024 Nov.
Article em En | MEDLINE | ID: mdl-39128626
ABSTRACT

AIM:

Whereas the prevalence of lymph node level (LNL) involvement in oral cavity squamous cell carcinomas (OCSCC) has been reported, the details of lymphatic progression patterns are insufficiently quantified. We investigate how the risk of metastases in each LNL depends on the involvement of adjacent LNLs, T-category, subsite, primary tumor lateralization, and other risk factors.

METHODS:

We retrospectively analyzed patients with newly diagnosed OCSCC from two institutions, totaling 348 patients. Involvement of LNLs I-V was recorded individually based on pathology after neck dissection with clinicopathological factors. The dataset is publicly available in a previously developed web-app, which allows querying patients with specific combinations of co-involved LNLs and tumor characteristics.

RESULTS:

Ipsilateral involvement prevalence of levels I-III was higher for advanced T-category (T3/T4) patients (32 %, 38 %, 14 %) compared to early (T1/T2) patients (14 %, 23 %, 11 %). Involvement of level I increased the involvement probability in levels II and III. Similarly, involvement of level II increased the involvement probability in levels I and III. However, there was significant isolated involvement of level I or II. Advanced nodal involvement (>1 LNL involved) was more frequent for patients with extracapsular extension. Overall contralateral involvement in levels I-III was 7 %, 4 %, 3 % and more frequent for more advanced ipsilateral involvement and for midline-crossing tumors. Involvement of levels IV and V was rare 3 % ipsilateral and 1 % contralateral in both levels.

CONCLUSIONS:

Detailed quantification of LNL involvement in OCSCC depending on involvement of adjacent LNLs and clinicopathological factors may allow further personalizing guidelines on elective nodal treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Linfonodos / Metástase Linfática Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Linfonodos / Metástase Linfática Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article